The Longevity Shift: A New Era of Physician Engagement in Longevity Medicine

Wellness-driven patients are changing clinical consultations. They arrive with wearable data, biological age questions, and expectations shaped by digital science communicators—no longer engaging with medicine only when something goes wrong.

For physicians, this raises a difficult question: how far can they go in prescribing for "healthy" people – in systems still built around diagnosed disease? For pharma and biotech, the implication is clear: traditional HCP engagement models are unlikely to be sufficient in this emerging space.

In this Point of View, Ipsos expert Pelin Tozan explores:

• How clinicians think about longevity medicine - balancing curiosity, evidence gaps, liability, and system constraints
• Why structural factors (reimbursement, visit lengths, team dynamics) make longevity conversations hard to sustain
• The role of conferences, professional forums, and social media in shaping physician awareness
• A practical framework for education-led engagement that supports physicians rather than adding burden

This Ipsos Point of View is particularly relevant for life sciences teams who are exploring how to make longevity medicine work with physicians.